Category Archives: Health Care

Lilly Brings Critical Obesity Information Closer to UAE Community Through Nationwide Awareness Campaign

Appearing in popular healthcare facilities and community venuesacross the UAE, the campaign empowered the local community with personalized science-based information about their health

United Arab Emirates, 23December 2025 – Lilly, a leading medicine company, has reached more than 3,000 UAE residents and visitors through a nationwide obesity awareness roadshow, bringing critical information about obesity closer to communities and supporting the UAE’s wider healthcare ambitions.

The Lilly Obesity Roadshow made appearances in key healthcare facilities and popular community venues across Abu Dhabi and Dubai, from 19 September to 16 December 2025, educating public on obesity classifications, risks and holistic management pathways while encouraging proactive healthcare. Through expert-led engagements and interactive wellness touchpoints, participants gained a clearer view of their health status and learned how timelyaction against obesity could help improve long-term health outcomes.

Continue reading Lilly Brings Critical Obesity Information Closer to UAE Community Through Nationwide Awareness Campaign

Wegovy® pill approved in the US as first oral GLP-1for weight management

  • Wegovy® pill showed a mean weight loss of 16.6% in the OASIS 4 trial[1]
  • Wegovy® pill is indicated to reduce excess body weight and maintain weight reduction long-term and to reduce the risk of major adverse cardiovascular events*
  • Novo Nordisk expects to launch Wegovy® pill in the US in early January 2026

Dubai, 24 December 2025- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the Wegovy® pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse cardiovascular events*.

Mike Doustdar, president and CEO of Novo Nordisk

Continue reading Wegovy® pill approved in the US as first oral GLP-1for weight management

It’s a new era for knee replacements and other joint surgeries

Not so long ago, undergoing a total hip or knee replacement and recovery was a grueling and often painful ordeal. While these are still major surgeries, new techniques and technologies are redefining them — and improving people’s outcomes, explains Dr. Brandon Bukowski, an orthopedic surgeon at the Mayo Clinic Health System in Mankato.

Continue reading It’s a new era for knee replacements and other joint surgeries

UAE’s Medcare among first centres outside the US to offer new SMA treatment for patients over two years of age

The newly licensed intrathecal gene therapy, enhances life-changing treatment options for children and families affected by Spinal Muscular Atrophy

Dubai, UAE–22December 2025: Families who were previously informed that their children had outgrown the eligibility for SMA gene therapy or were deemed not the right weight, now have renewed hope. Medcare Royal Speciality Hospital in Al Qusais has become among the first centres outside the USA to offer a newly licensed intrathecal gene therapy for Spinal Muscular Atrophy (SMA).

This treatment can now be administered to SMA patients well into their childhood and beyond. Approved after a thorough global assessment for intrathecal use, this therapy is tailored for children, teenagers, and adults, effectively removing the weight restrictions that have historically hindered access to gene therapy for this rare neuromuscular disorder.The milestone solidifies the UAE’s position at the forefront of cutting-edge genetic medicine and brings new hope to thousands of families worldwide.

Continue reading UAE’s Medcare among first centres outside the US to offer new SMA treatment for patients over two years of age